학술논문
Surufatinib combined camrelizumab as a valuable third-line rescue therapy for a patient with extensive-stage for small-cell lung cancer: a case report and literature review.
Document Type
Article
Author
Source
Anti-Cancer Drugs; Mar2024, Vol. 35 Issue 3, p271-276, 6p
Subject
Language
ISSN
09594973